Kathryn Mishkin
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0003-0050-8106Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Fergus Couch, Qixin Li, Sam Hillman, Linlin Luo, Jennifer Hayes +3 more
Papers
Driven by 2 papers — median percentile 38. Top paper: “Real-world tumor BRCA testing patterns and PARP inhibitor use in HER2-negative metastatic breast cancer.”.
Fergus Couch, Qixin Li, Sam Hillman, Linlin Luo, Jennifer Hayes +3 more
Julia Chowdhury, Cynthia A. Moore, Martha M. Werler, Kathryn Mishkin, Jennita Reefhuis +1 more